RadNet earnings release, May 11, 2026

RadNet, Inc. (RDNT) · Form 8-K, Item 2.02 · Filed · SEC filing

RadNet Reports Record First Quarter Financial

Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow

LOS ANGELES, California, May 10, 2026 – RadNet,

Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 435 outpatient imaging centers and a premier developer of radiology digital health solutions, today reported financial results for its first quarter of 2026.

Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “After being impacted by severe winter weather conditions in the Northeast during January and February which reduced Revenue and Adjusted EBITDA

Financial statements

Income Statement

Imaging Center Segment

Original Guidance RangeRevised Guidance Range
Total Net Revenue$2,325 - $2,375 million$2,355 - $2,405 million
Adjusted EBITDA(1)$335 - $348 million$340 - $353 million
Capital Expenditures(a)$165 - $175 million$165 - $175 million
Cash Interest Expense(b)$45 - $50 million$45 - $50 million
Free Cash Flow(2)$105 - $115 million$112 - $122 million

Income Statement

Digital Health Segment

Original Guidance RangeRevised Guidance Range
Total Net Revenue$135 - $145 million$135 - $145 million
Adjusted EBITDA(1) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$10 - $12 million$10 - $12 million
Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$17 - $19 million$17 - $19 million
Capital Expenditures$9 - $12 million$9 - $12 million
Free Cash Flow(2) Before Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$(1) - $3 million$(1) - $3 million
Free Cash Flow(2) After Non-Capitalized R&D - DeepHealth Cloud OS & Generative AI$(17) - $(19) million$(17) - $(19) million

Income Statement

Three Months Ended March 31, — (unaudited) (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Service fee revenue545,218439,349
Revenue under capitation arrangements30,41332,050
Total service revenue575,631471,399
OPERATING EXPENSESCost of operations, excluding depreciation and amortization550,512453,480
OPERATING EXPENSESLease abandonment charges5,388
OPERATING EXPENSESDepreciation and amortization44,96735,483
OPERATING EXPENSESLoss (gain) on sale and disposal of equipment and other2,591402
OPERATING EXPENSESSeverance costs1,464747
OPERATING EXPENSESTotal operating expenses599,534495,500
OPERATING EXPENSESINCOME (LOSS) FROM OPERATIONS-23,903-24,101
OTHER INCOME AND EXPENSESInterest expense17,65717,239
OTHER INCOME AND EXPENSESEquity in earnings of joint ventures-3,825-2,599
OTHER INCOME AND EXPENSESNon-cash change in fair value of interest rate hedge2,106
OTHER INCOME AND EXPENSESOther (income) expenses-4,907-7,712
OTHER INCOME AND EXPENSESTotal other (income) expenses8,9259,034
OTHER INCOME AND EXPENSESINCOME (LOSS) BEFORE INCOME TAXES-32,828-33,135
OTHER INCOME AND EXPENSESProvision for income taxes8,0963,398
OTHER INCOME AND EXPENSESNET INCOME (LOSS)-24,732-29,737
OTHER INCOME AND EXPENSESNet income (loss) attributable to noncontrolling interests8,7348,189
OTHER INCOME AND EXPENSESNET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS-33,466-37,926
OTHER INCOME AND EXPENSESBASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS-0.43-0.51
OTHER INCOME AND EXPENSESDILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS-0.43-0.51
WEIGHTED AVERAGE SHARES OUTSTANDINGBasic77,057,83574,382,356
WEIGHTED AVERAGE SHARES OUTSTANDINGDiluted77,057,83574,382,356

Income Statement

Three Months Ended March 31, — (unaudited) (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025(iv)
NET LOSS INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS-33,466-37,926
Add Non-cash change in fair value of interest rate hedges (i)2,106
Add Non-operational rent expenses (iii)9001,342
Add Acquisition transaction costs3,454672
Add loss on sale and disposal of equipment and other2,591402
Add Severance costs1,464747
Add Lease abandonment charges5,388
Add Change to contingent consideration2,764
Add Non-capitalized R&D - DeepHealth cloud OS & generative AI4,5603,562
Total adjustments - loss (gain)15,73314,219
Subtract tax impact of Adjustments (ii)-3,880-1,459
Tax effected impact of adjustments11,85312,760
TOTAL ADJUSTMENT TO NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS11,85312,760
ADJUSTED NET LOSS ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS-21,613-25,166
WEIGHTED AVERAGE SHARES OUTSTANDINGDiluted77,057,83574,382,356
WEIGHTED AVERAGE SHARES OUTSTANDINGADJUSTED DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS-0.28-0.34

Balance Sheet

March 31, 2026 — (IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)

March 31, 2026 – (unaudited)December 31, 2025
CURRENT ASSETSCash and Cash equivalents455,339767,215
CURRENT ASSETSAccounts receivable209,090200,317
CURRENT ASSETSDue from affiliates11,03312,592
CURRENT ASSETSPrepaid expenses and other current assets65,31352,003
CURRENT ASSETSTotal current assets740,7751,032,127
PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETSProperty and equipment, net862,057807,702
PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETSOperating lease right-of-use assets760,975690,250
PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETSTotal property, plant, equipment and right-of-use assets1,623,0321,497,952
OTHER ASSETSGoodwill1,094,699907,663
OTHER ASSETSOther intangible assets253,481148,508
OTHER ASSETSDeferred financing costs1,5381,684
OTHER ASSETSInvestment in joint ventures131,409130,340
OTHER ASSETSDeposits and other40,45540,289
OTHER ASSETSTotal Assets3,885,3893,758,563
CURRENT LIABILITIESAccounts payable, accrued expenses and other454,602422,029
CURRENT LIABILITIESDue to affiliates75,96070,104
CURRENT LIABILITIESDeferred revenue11,9757,272
CURRENT LIABILITIESCurrent operating lease liability66,59161,934
CURRENT LIABILITIESCurrent portion of notes payable26,50625,424
CURRENT LIABILITIESTotal current liabilities635,634586,763

Cash Flow

Three Months Ended March 31, — (unaudited) (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net loss-24,732-29,737
Adjustments to reconcile net loss to net cash provided by operating activities:Depreciation and amortization44,96735,483
Adjustments to reconcile net loss to net cash provided by operating activities:Noncash operating lease expense16,29814,431
Adjustments to reconcile net loss to net cash provided by operating activities:Equity in earnings of joint ventures, net of dividends-1,069-2,599
Adjustments to reconcile net loss to net cash provided by operating activities:Amortization of deferred financing costs and loan discount779728
Adjustments to reconcile net loss to net cash provided by operating activities:Loss on sale and disposal of equipment2,591402
Adjustments to reconcile net loss to net cash provided by operating activities:Lease abandonment charges5,388
Adjustments to reconcile net loss to net cash provided by operating activities:Amortization of cash flow hedge1,033
Adjustments to reconcile net loss to net cash provided by operating activities:Non-cash change in fair value of interest rate swap2,106
Adjustments to reconcile net loss to net cash provided by operating activities:Stock-based compensation31,37528,494
Adjustments to reconcile net loss to net cash provided by operating activities:Change in fair value of contingent consideration-2,764
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Accounts receivable9,375-14,306
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Other current assets-6,172-7,206
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Other assets-660-1,691
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Deferred taxes-9,0995,137
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Operating leases-13,299-21,968
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Deferred revenue234128
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Accounts payable, accrued expenses and other31,14825,658
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:Net cash provided by operating activities78,97241,481
CASH FLOWS FROM INVESTING ACTIVITIESPurchase of imaging facilities and other acquisitions, net of cash acquired-304,151-3,794
CASH FLOWS FROM INVESTING ACTIVITIESPurchase of property and equipment and other-69,932-48,833
CASH FLOWS FROM INVESTING ACTIVITIESProceeds from sale of equipment27723
CASH FLOWS FROM INVESTING ACTIVITIESEquity contributions in existing and purchase of interest in joint ventures-4,147
CASH FLOWS FROM INVESTING ACTIVITIESCollection of notes receivable2,833
CASH FLOWS FROM INVESTING ACTIVITIESNet cash used in investing activities-370,973-56,751
CASH FLOWS FROM FINANCING ACTIVITIESPrincipal payments on notes and leases payable-9,953-1,718
CASH FLOWS FROM FINANCING ACTIVITIESPayments on Term Loan Debt-5,252-5,000
CASH FLOWS FROM FINANCING ACTIVITIESDistributions paid to noncontrolling interests-2,402-913
CASH FLOWS FROM FINANCING ACTIVITIESProceeds from issuance of common stock upon exercise of options103121
CASH FLOWS FROM FINANCING ACTIVITIESNet cash used in financing activities-17,504-7,510
CASH FLOWS FROM FINANCING ACTIVITIESEFFECT OF EXCHANGE RATE CHANGES ON CASH-2,37183
CASH FLOWS FROM FINANCING ACTIVITIESNET DECREASE IN CASH AND CASH EQUIVALENTS-311,876-22,697
CASH FLOWS FROM FINANCING ACTIVITIESCASH AND CASH EQUIVALENTS, beginning of period767,215740,020
CASH FLOWS FROM FINANCING ACTIVITIESCASH AND CASH EQUIVALENTS, end of period455,339717,323
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATIONCash paid during the period for interest17,07318,010
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATIONCash paid during the period for income taxes519272
Full release

(1) by an estimated $13 million and $9 million, respectively, our business strongly rebounded in March, resulting in a Total Company Revenue increase of 22.1% and a Total Company Adjusted EBITDA

(1) increase of 36.3% from last year’s first quarter. The record first quarter performance was driven by aggregate advanced imaging (MRI, CT and PET/CT) growth of 19.7% and same-center advanced imaging growth of 8.2% as compared with the first quarter of last year. The growth in MR, CT and PET/CT contributed to a 235 basis point shift in RadNet’s advanced imaging procedural volume mix (relative to routine imaging) as compared with the same quarter last year, increasing from 26.9% in last year’s first quarter to 29.3% in the first quarter of 2026. Imaging

Center Adjusted EBITDA

(1) margin increased by 52 basis points, after adjusting for lost Revenue and Adjusted EBITDA

(1) from the severe winter weather in this year’s first quarter and the severe winter weather and California wildfires in last year’s first quarter.”

Dr. Berger continued, “On April 30th, we announced the commencement of a new health system joint venture with Trinity Health’s Saint Alphonsus Health System initially with five outpatient imaging centers in Boise, Idaho. In conjunction with this new partnership, various modules of DeepHealth OS as well as AI-powered solutions for radiologist reporting, patient engagement and clinical interpretation will be implemented. This relationship is a blueprint for future health system partnerships, where RadNet can bring all of its operational, clinical and digital workflow solutions to bear to streamline the patient journey and improve medical care and outcomes. As a result of the strong operating trends during the first quarter which have continued through early May, we are increasing 2026 Imaging Center guidance for Revenue, Adjusted EBITDA

(1) and Free Cash Flow

(2).”

“The Digital Health division continues to gain momentum, which was further advanced with the March 2, 2026 acquisition of Gleamer SAS in France. DeepHealth’s clinical AI portfolio now includes interpretive solutions in virtually all imaging modalities. We estimate that by the end of this year, over 70% of RadNet studies could be running through clinical AI, and we expect that all of RadNet’s radiologist reports will be processed through DeepHealth’s

Reporting Pro AI-powered auto-impression/summarization engine. When fully implemented, these initiatives should result in significant enhancement to patient care and workflow productivity intended to achieve a measurable improvement to RadNet’s operating expenses.

Furthermore, the Digital Health sales pipeline with third-party customers continued to build during the first quarter, during which we signed over $16 million (Total Contract Value) of new DeepHealth business. These contracts span the full breadth of DeepHealth products including clinical AI, operating and diagnostic workflow and TechLive solutions,” added Dr. Berger.

“RadNet’s balance sheet continues to be among the strongest in the diagnostic imaging industry. At quarter end, which reflected the acquisition of Gleamer and recent imaging center transactions, we had a cash balance of $455.3 million and a leverage ratio of Net Debt to Adjusted EBITDA

(1) of slightly below 2.0. Financial leverage and liquidity will continue to be carefully managed to maintain optimal future operating flexibility,” concluded Dr. Berger.

Financial Results

For the first quarter of 2026, RadNet reported Total

Company Revenue of $575.6 million and Adjusted EBITDA

(1) of $63.3 million. Revenue increased $104.2 million (or 22.1%) and

Adjusted EBITDA

(1) increased $16.9 million (or 36.3%) as compared with the first quarter of 2025.

For the first quarter of 2026, RadNet reported Digital

Health Revenue (inclusive of intersegment revenue) of $29.1 million and Adjusted EBITDA

(1) of $1.3 million. Revenue increased

$9.9 million (or 51.5%) and Adjusted EBITDA

(1) decreased $2.4 million as compared with the first quarter of 2025. At March 31, 2026, Annual Recurring Revenue

(4)

(ARR) for Digital Health was $96.9 million, as compared with $49.8 million as of March 31, 2025.

There were a number of unusual or one-time items impacting the first quarter including: $0.9 million expense related to leases for de novo facilities under construction that have yet to open their operations; $3.5 million of acquisition transaction costs; $2.6 million loss on the sale and disposal of equipment; $1.5 million of severance costs; $2.8 million change in contingent consideration related to past acquisitions; and $4.6 million of non-capitalized research and development expenses with respect to DeepHealth Cloud OS and generative AI. Adjusting for the above items, Total Company Adjusted Loss

(3) was $21.6 million and diluted Adjusted Loss Per Share

(3) was $(0.28) for the first quarter of 2026. This compares with Total

Company Adjusted Loss

(3) of $25.2 million and diluted Adjusted Loss Per Share

(3) of $(0.34) during the first quarter of 2025.

Unadjusted for unusual or one-time items impacting... (truncated) 2026, Total Company Net Loss for the first quarter of 2026 was $33.5 million as compared with a Total Company Net

Loss of $37.9 million for the first quarter of 2025. Net Loss Per Share for the first quarter of 2026 was $(0.43), compared with a Net

Loss per share of $(0.51) in the first quarter of 2025, based upon a weighted average number of diluted shares outstanding of 77.1 million shares in 2026 and 74.4 million shares in 2025.

For the first quarter of 2026, as compared with the prior year’s first quarter, MRI volume increased 20.3%, CT volume increased 17.7% and PET/CT volume increased 35.2% on a systemwide basis (including unconsolidated joint venture centers). Overall volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 10.1% over the prior year’s first quarter. On a same-center systemwide basis, including only those centers which were part of RadNet for both the first quarters of 2026 and 2025, MRI volume increased 10.0%, CT volume increased 4.7% and PET/CT volume increased 14.7%. Overall same-center volume, taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 2.4% over the prior year’s same quarter.

2026 Revised Guidance

RadNet amends its previously announced guidance levels as follows:

Imaging Center Segment

Digital Health Segment

Financial Results Conference Call

Dr. Howard Berger, President and Chief Executive Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call to discuss its first quarter 2026 results on Monday, May 11th, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

Conference Call Details:

Date: Monday, May 11, 2026

Time: 10:30 a.m. Eastern Time

Dial In-Number: 844-744-1280

International Dial-In Number: 412-564-6465

It is recommended that participants dial in approximately 5 to 10 minutes prior to the start of the 10:30 a.m. call. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1761306&tp_key=ea5d61284c or http://www.radnet.com under the “Investors” menu section and “News Releases” sub-menu of the website. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international allers, and using the passcode 10208825.

About RadNet, Inc.

RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and/or operated outpatient imaging centers. RadNet’s imaging center markets include Arizona,

California, Delaware, Florida, Idaho, Indiana, Maryland, New Jersey, New York, Texas and Virginia. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry globally. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 11,000 team members. Learn more at radnet.com.

Forward Looking Statements

This press release contains

“forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform

Act of 1995. Forward-looking statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified by words such as: “anticipate,” “intend,” “plan,” “goal,” “seek,”

“believe,” “project,” “estimate,” “expect,” “strategy,” “future,”

“likely,” “may,” “should,” “will” and similar references to future periods.

Forward-looking statements are neither historical facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control.

Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:

The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included elsewhere. Additional information concerning risks, uncertainties and assumptions can be found in RadNet's filings with the SEC, including the risk factors discussed in RadNet's most recent Annual Report on Form 10-K, as updated by its Quarterly Reports on Form 10-Q and future filings with the SEC.

Any forward-looking statement contained in this release is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of changed circumstances, new information, future developments or otherwise, except as required by applicable law.

Regulation G: GAAP and Non-GAAP Financial Information

This release contains certain financial information... (truncated)ompany believes that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this release in the tables which follow.

CONTACTS:

RadNet, Inc.

Mark Stolper, 310-445-2800

Executive Vice President and Chief Financial

Officer

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · RadNet earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.